clinical trial · NCT07623915
A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid
CSPC Ouyi Pharmaceutical Co., Ltd.·phase3·not yet recruiting·n = 222
Primary HyperlipidemiaBempedoic Acid TabletPlacebo
brief summary
This trial is a multicenter randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
started
Jun 12, 2026
primary completion
Jun 30, 2027
completion
Aug 28, 2027
last updated
Jun 3, 2026
official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid in Patients With Hyperlipidemia Not Adequately Controlled by Statins
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol